You have 9 free searches left this month | for more free features.

HS-20093

Showing 51 - 75 of 549

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Healthy Trial in Haikou (HS-20090, Xgeva®)

Not yet recruiting
  • Healthy
  • Haikou, Hainan, China
    Haikou People's Hospital
Mar 8, 2023

Hidradenitis Suppurativa Trial in Worldwide (Bimekizumab, Placebo)

Active, not recruiting
  • Hidradenitis Suppurativa
  • Birmingham, Alabama
  • +87 more
Feb 2, 2023

Advanced or Metastatic NSCLC Trial in Guangzhou (HS-10375)

Recruiting
  • Advanced or Metastatic NSCLC
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Jun 27, 2022

Hidradenitis Suppurativa Trial (SAR442970, Placebo)

Not yet recruiting
  • Hidradenitis Suppurativa
  • (no location specified)
Apr 28, 2023

Nontuberculous Mycobacterial Lung Disease, Nontuberculous Mycobacterium Infection Trial in New York, Portland, Toronto

Recruiting
  • Nontuberculous Mycobacterial Lung Disease
  • Nontuberculous Mycobacterium Infection
  • Hypertonic saline
  • +3 more
  • New York, New York
  • +2 more
Jan 27, 2023

Hidradenitis Suppurativa Trial (Eltrekibart, Placebo)

Not yet recruiting
  • Hidradenitis Suppurativa
  • (no location specified)
Sep 14, 2023

Advanced Non-Small-Cell Lung Cancer Trial in Tianjin (HS-10376)

Recruiting
  • Advanced Non-Small-Cell Lung Cancer
  • Tianjin, Tianjin, China
    Tianjin Medical University Cancer Institute and Hospital
Jun 27, 2022

Colorectal Polyp Trial (Cold snare endoscopic mucosal resection, Hot snare endoscopic mucosal resection)

Recruiting
  • Colorectal Polyp
  • Cold snare endoscopic mucosal resection
  • Hot snare endoscopic mucosal resection
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
Oct 15, 2022

Hidradenitis Suppurativa, Quality of Life Trial in Bronx

Completed
  • Hidradenitis Suppurativa
  • Quality of Life
    • Bronx, New York
      Montefiore Medical Center
    Jan 18, 2023

    Hidradenitis Suppurativa Mail Survey

    Active, not recruiting
    • Hidradenitis Suppurativa
      • Winston-Salem, North Carolina
        Wake Forest Baptist Medical Center
      Jun 28, 2022

      Breast Cancer Trial in Shanghai (HS-10352 combined with fulvestrant (Stage 1), HS-10352 combined with fulvestrant (Stage 2))

      Recruiting
      • Breast Cancer
      • HS-10352 combined with fulvestrant (Stage 1)
      • HS-10352 combined with fulvestrant (Stage 2)
      • Shanghai, Shanghai, China
        Fudan University Shanghai Cancer Center
      Aug 15, 2022

      Hidradenitis Suppurativa (HS) Trial (secukinumab)

      Available
      • Hidradenitis Suppurativa (HS)
      • (no location specified)
      Oct 20, 2022

      MDD (MDD) Trial (HS-10353 30mg oral capsules, HS-10353 50mg oral capsules, Placebo for HS-10353 30mg capsules)

      Not yet recruiting
      • Major Depressive Disorder (MDD)
      • HS-10353 30mg oral capsules
      • +3 more
      • (no location specified)
      Jul 10, 2023

      Advanced Solid Tumor Trial in Wuhan (HS-10370)

      Not yet recruiting
      • Advanced Solid Tumor
      • Wuhan, Hubei, China
        Union Hospital Tong Ji Medical College, HuaZhong University of S
      May 5, 2022

      Advanced Solid Tumor Trial in Xi'an (HS-10381)

      Recruiting
      • Advanced Solid Tumor
      • Xi'an, Sichuan, China
        West China Hospital of Sichuan University
      Jul 4, 2022

      Hidradenitis Suppurativa Trial in Worldwide (Bimekizumab, Placebo)

      Completed
      • Hidradenitis Suppurativa
      • Fountain Valley, California
      • +90 more
      Nov 8, 2022

      Nonsmall Cell Lung Cancer Trial in Anaheim, Beverly Hills, Aurora (HS-10296)

      Active, not recruiting
      • Nonsmall Cell Lung Cancer
      • Anaheim, California
      • +9 more
      Dec 27, 2022

      Collect inReal-world populatIon Data on Treatment Pattern of

      Not yet recruiting
      • Hidradenitis Suppurativa
      • secukinumab
      • (no location specified)
      Jun 26, 2023

      Periodontal Disease and Diabetes Mellitus

      Completed
      • Periodontitis, Adult
      • GCF levels of fetuin A and hsCRP evaluation
      • Fayoum, Egypt
        faculty of dentistry, Fayoum university
      Sep 26, 2023

      Behavior, Eating Trial (High-Fat/High-Sugar (HF/HS) Diet, Low-Fat/Low-Sugar (LF/LS) Diet)

      Completed
      • Behavior, Eating
      • High-Fat/High-Sugar (HF/HS) Diet
      • Low-Fat/Low-Sugar (LF/LS) Diet
      • (no location specified)
      Oct 7, 2022

      Hidradenitis Suppurativa, Hyperhidrosis Trial in Pittsburgh (Botulinum toxin)

      Recruiting
      • Hidradenitis Suppurativa
      • Hyperhidrosis
      • Botulinum toxin
      • Pittsburgh, Pennsylvania
        University of Pittsburgh Medical Center = Presbyterian Shadyside
      Jul 5, 2022

      Hidradenitis Suppurativa (HS) Trial (blood sampling)

      Not yet recruiting
      • Hidradenitis Suppurativa (HS)
      • blood sampling
      • (no location specified)
      Feb 9, 2023

      Hidradenitis Suppurativa Trial in United States (INCB054707)

      Completed
      • Hidradenitis Suppurativa
      • Los Angeles, California
      • +3 more
      Sep 14, 2022

      Essential Hypertension Trial (NW Roselle, Captopril 25Mg Tab)

      Not yet recruiting
      • Essential Hypertension
      • NW Roselle
      • Captopril 25Mg Tab
      • (no location specified)
      Nov 15, 2023

      Hidradenitis Suppurativa (HS) Trial in Worldwide (Povorcitinib, Placebo)

      Recruiting
      • Hidradenitis Suppurativa (HS)
      • Phoenix, Arizona
      • +44 more
      Jan 12, 2023